Fig. 5From: 11C-acetate PET/MRI in bladder cancer staging and treatment response evaluation to neoadjuvant chemotherapy: a prospective multicenter study (ACEBIB trial)Comparison of lymph node staging (N-stage) on pre-transurethral resection (a, b, c) and post-chemotherapy 11C-acetate PET/MRI (d, e, f) in patient number 12, the same patient as in Fig. 4. 17Â mm right obturator lymph node (a - white arrow on T2-weighted image) demonstrated increased diffusion signal restriction (b - b value 800Â s/mm2 trace diffusion weighted image) and increased 11C-acetate uptake (c - PET fused with T2-weighted image, SUV is scaled from 0.0 to 3.5) suggestive of lymph node metastasis. On post-chemotherapy 11C-acetate PET/MRI, lymph node decreased in size and measured 4Â mm (d - green arrow on T2-weighted image) with increased diffusion signal (e - b value 800Â s/mm2 trace diffusion weighted image) and increased 11C-acetate uptake (f - PET fused with T2-weighted image, SUV is scaled from 0.0 to 3.0). SUVmax values of the lymph node on the pre-transurethral resection (c) and post-chemotherapy 11C-acetate PET/MRI (f) were 3.4 and 2.8, respectively. The lymph node was confirmed to be lymph node metastasis measuring 3Â mm on extended pelvic lymph node dissection, thus the findings of 11C-acetate PET/MRI were considered as true positiveBack to article page